Results 211 to 220 of about 694,423 (327)

Predicting Hepatic Decompensation in Patients With Metabolic Dysfunction Associated Steatotic Liver Disease‐Related Cirrhosis: The ABID‐LSM Model

open access: yesAlimentary Pharmacology &Therapeutics, Volume 62, Issue 5, Page 526-535, September 2025.
The ABID‐LSM score, a combination of liver stiffness measurement and easily obtainable clinical and laboratory factors, can accurately predict the risk of hepatic decompensation in patients with MASLD and cirrhosis. ABSTRACT Background & Aims Predicting the risk of hepatic decompensation guides prognostication and therapy; however, it is challenging in
Luis Calzadilla Bertot   +14 more
wiley   +1 more source

Chemotactic Zn micromotor for treatment of high blood ammonia-associated hepatic encephalopathy. [PDF]

open access: yesNat Commun
Feng Y   +10 more
europepmc   +1 more source

Liver Transplantation for Primary Biliary Cirrhosis [PDF]

open access: yes, 1989
Carcassonne, Christian   +4 more
core   +1 more source

Lymphocyte‐to‐Monocyte Ratio as a Predictor of Recompensation in Patients With Decompensated Primary Biliary Cholangitis

open access: yesAlimentary Pharmacology &Therapeutics, Volume 62, Issue 6, Page 646-655, September 2025.
This study identifies lymphocyte‐to‐monocyte ratio as a robust independent predictor for recompensation in decompensated primary biliary cholangitis patients, demonstrating superior predictive performance compared to other inflammatory markers and an accessible prognostic tool for clinical management.
Huiying Lin   +11 more
wiley   +1 more source

Challenges of designing hepatic encephalopathy treatment trials [PDF]

open access: bronze, 2003
Madhusudhan R. Sanaka   +2 more
openalex   +1 more source

Portal-systemic shunting for metabolic disease [PDF]

open access: yes, 1985
Iwatsuki, S, Porter, KA, Starzl, TE
core  

Home - About - Disclaimer - Privacy